Trimble (NASDAQ:TRMB) expects Q4 revenue of $560M-$590M and EPS of $0.26-$0.32, well below a consensus of $638M and $0.41.
CEO Steven Berglund, discussing Trimble's Q3: "While we recorded a year-over-year increase in revenue, the quarter was unimpressive. Our results in agriculture and Europe were both weaker than we originally anticipated."
Seattle Genetics (NASDAQ:SGEN) now expects full-year U.S./Canada Adcetris net product sales of $172M-$177M, better than prior guidance of $160M-$170M. Collaboration revenue (also better than expected) is now forecast to total $64M-$68M.
Q3 Adcetris net sales +32% Y/Y to $48.2M. Collaboration revenue -33% to $19.5M. Costs/expenses -3% to $91.5M.
Imperva (NYSE:IMPV) expects Q4 revenue of $48.6M-$50.6M and EPS of -$0.02 to -$0.07, favorable at the midpoints to a consensus of $48.8M and -$0.07.
A 36% Y/Y increase in services revenue (54% of total revenue) to $23M fueled the Q3 beat. Within services, subscription revenue rose 108% to $6.4M. Palo Alto Networks, FireEye, and several other security tech names have also been seeing strong subscription growth.
$100K+ deals rose to 106 from 97 a year ago, and new customers to 183 from 148.
Shares have now nearly doubled from their spring lows. They remain down over 50% from a March high of $67.12.